Skip to content

A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002)

Proprietary Information - Exploratory (Non-Confirmatory) Trial

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00424424
Enrollment
81
Registered
2007-01-19
Start date
2006-08-31
Completion date
2007-01-31
Last updated
2015-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

Postoperative Dental Pain

Brief summary

This study is being conducted to evaluate the safety and tolerability of the drug and to evaluate its efficacy compared to placebo and to ibuprofen in the prevention of postoperative dental pain in male patients. This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

Interventions

DRUGMK0719

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

: * Patients in generally good health who are scheduled to have 2 or more third molars removed, at least 1 of which is partially or completely embedded in bone and is a mandibular impaction

Exclusion criteria

: * Patient has a history of any illness or condition that, in the opinion of the investigator, might confound the results of the study or pose additional risk to the patient

Design outcomes

Primary

MeasureTime frame
Proprietary Information - Exploratory (Non-Confirmatory) Trial

Secondary

MeasureTime frame
Proprietary Information - Exploratory (Non-Confirmatory) Trial

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026